Annual EPS:
-$0.98+$1.65(+62.65%)Summary
- As of today, GLUE annual earnings per share is -$0.98, with the most recent change of +$1.65 (+62.65%) on December 31, 2024.
- During the last 3 years, GLUE annual EPS has risen by +$0.61 (+38.11%).
- GLUE annual EPS is now -459.18% below its all-time high of -$0.18, reached on December 31, 2019.
Performance
GLUE EPS Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly EPS:
-$0.33-$0.18(-119.72%)Summary
- As of today, GLUE quarterly earnings per share is -$0.33, with the most recent change of -$0.18 (-119.72%) on September 30, 2025.
- Over the past year, GLUE quarterly EPS has dropped by -$0.04 (-12.99%).
- GLUE quarterly EPS is now -158.16% below its all-time high of $0.57, reached on March 31, 2025.
Performance
GLUE Quarterly EPS Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EPS:
$0.31-$0.04(-11.01%)Summary
- As of today, GLUE TTM earnings per share is $0.31, with the most recent change of -$0.04 (-11.01%) on September 30, 2025.
- Over the past year, GLUE TTM EPS has increased by +$2.14 (+116.67%).
- GLUE TTM EPS is now -11.01% below its all-time high of $0.34, reached on June 30, 2025.
Performance
GLUE TTM EPS Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EPS Formula
EPS = Net Income - Preferred Dividends
Shares Outstanding
Net Income - Preferred Dividends
Shares Outstanding
Shares Outstanding
GLUE EPS Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | +62.6% | -13.0% | +116.7% |
| 3Y3 Years | +38.1% | +43.8% | +114.1% |
| 5Y5 Years | -459.2% | -123.6% | +183.3% |
GLUE EPS Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | at high | +62.6% | -158.2% | +53.8% | -11.0% | +111.3% |
| 5Y | 5-Year | -459.2% | +62.6% | -158.2% | +53.8% | -11.0% | +111.3% |
| All-Time | All-Time | -459.2% | +62.6% | -158.2% | +53.8% | -11.0% | +111.3% |
GLUE EPS History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2025 | - | -$0.33(-119.7%) | $0.31(-11.0%) |
| Jun 2025 | - | -$0.15(-126.5%) | $0.34(+410.0%) |
| Mar 2025 | - | $0.57(+158.7%) | $0.07(+106.5%) |
| Dec 2024 | -$0.98(+62.7%) | $0.22(+175.1%) | -$1.03(+43.8%) |
| Sep 2024 | - | -$0.29(+31.6%) | -$1.83(+18.3%) |
| Jun 2024 | - | -$0.43(+19.9%) | -$2.24(+11.3%) |
| Mar 2024 | - | -$0.53(+9.0%) | -$2.53(+4.5%) |
| Dec 2023 | -$2.63(-14.6%) | -$0.58(+16.6%) | -$2.65(+1.7%) |
| Sep 2023 | - | -$0.70(+1.6%) | -$2.69(-4.5%) |
| Jun 2023 | - | -$0.71(-9.6%) | -$2.58(-5.9%) |
| Mar 2023 | - | -$0.65(-3.1%) | -$2.43(-5.9%) |
| Dec 2022 | -$2.30 | -$0.63(-7.7%) | -$2.29(-5.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2022 | - | -$0.58(-3.1%) | -$2.17(-7.8%) |
| Jun 2022 | - | -$0.57(-10.4%) | -$2.01(-8.3%) |
| Mar 2022 | - | -$0.51(-2.0%) | -$1.86(-14.5%) |
| Dec 2021 | -$1.59(-94.9%) | -$0.50(-18.0%) | -$1.62(-45.0%) |
| Sep 2021 | - | -$0.43(-3.4%) | -$1.12(-33.4%) |
| Jun 2021 | - | -$0.41(-47.9%) | -$0.84(-53.1%) |
| Mar 2021 | - | -$0.28(-89.8%) | -$0.55(-49.4%) |
| Dec 2020 | -$0.82(-363.6%) | - | - |
| Sep 2020 | - | -$0.15(-20.6%) | -$0.37(-66.9%) |
| Jun 2020 | - | -$0.12(-24.6%) | -$0.22(-124.6%) |
| Mar 2020 | - | -$0.10 | -$0.10 |
| Dec 2019 | -$0.18 | - | - |
FAQ
- What is Monte Rosa Therapeutics, Inc. annual earnings per share?
- What is the all-time high annual EPS for Monte Rosa Therapeutics, Inc.?
- What is Monte Rosa Therapeutics, Inc. annual EPS year-on-year change?
- What is Monte Rosa Therapeutics, Inc. quarterly earnings per share?
- What is the all-time high quarterly EPS for Monte Rosa Therapeutics, Inc.?
- What is Monte Rosa Therapeutics, Inc. quarterly EPS year-on-year change?
- What is Monte Rosa Therapeutics, Inc. TTM earnings per share?
- What is the all-time high TTM EPS for Monte Rosa Therapeutics, Inc.?
- What is Monte Rosa Therapeutics, Inc. TTM EPS year-on-year change?
What is Monte Rosa Therapeutics, Inc. annual earnings per share?
The current annual EPS of GLUE is -$0.98
What is the all-time high annual EPS for Monte Rosa Therapeutics, Inc.?
Monte Rosa Therapeutics, Inc. all-time high annual earnings per share is -$0.18
What is Monte Rosa Therapeutics, Inc. annual EPS year-on-year change?
Over the past year, GLUE annual earnings per share has changed by +$1.65 (+62.65%)
What is Monte Rosa Therapeutics, Inc. quarterly earnings per share?
The current quarterly EPS of GLUE is -$0.33
What is the all-time high quarterly EPS for Monte Rosa Therapeutics, Inc.?
Monte Rosa Therapeutics, Inc. all-time high quarterly earnings per share is $0.57
What is Monte Rosa Therapeutics, Inc. quarterly EPS year-on-year change?
Over the past year, GLUE quarterly earnings per share has changed by -$0.04 (-12.99%)
What is Monte Rosa Therapeutics, Inc. TTM earnings per share?
The current TTM EPS of GLUE is $0.31
What is the all-time high TTM EPS for Monte Rosa Therapeutics, Inc.?
Monte Rosa Therapeutics, Inc. all-time high TTM earnings per share is $0.34
What is Monte Rosa Therapeutics, Inc. TTM EPS year-on-year change?
Over the past year, GLUE TTM earnings per share has changed by +$2.14 (+116.67%)